Trial Profile
A Phase II Comparative Study between Weekly Administration of ABI-007 and Tri-weekly Administration of Docetaxel in Patients with Metastatic Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Docetaxel
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 27 May 2016 New trial record